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ABSTRACT
Inflammatory diseases such as proliferative glomerulonephritis
are associated with the production of nitric oxide (NO), which
can initiate apoptotic/necrotic cell death. We studied the role of
the p42/44 mitogen-activated protein kinases (MAPKs) and
c-Jun N-terminal kinases1/2 (JNK1/2) in NO-evoked cytotoxic-
ity in rat mesangial cells (MC). The NO donor S-nitrosogluta-
thione time- and concentration-dependently promoted apopto-
tic cell death as detected by JNK1/2 and caspase-3 activation
as well as DNA fragmentation. By using Ro 318220, a JNK1/2
activator, we established a correlation between apoptosis and
JNK1/2 activation. Apoptosis is antagonized by the addition of
fetal calf serum or the simultaneous generation of NO and
superoxide (O2
2), another biological inflammatory mediator.
Fetal calf serum-induced protection required p42/44 MAPK
activation as inhibition of the p42/44 MAPK pathway by the
MAPK kinase-1 inhibitor PD 98059 attenuated MC protection.
In contrast, cytoprotection by NO/O2
2 cogeneration demanded
reduced glutathione but was p42/44 MAPK unrelated. Deple-
tion of glutathione reversed NO/O2
2-evoked survival to cell
destruction and reinstalled JNK1/2 activity. In conclusion, dif-
ferent signal transduction pathways facilitate protection against
NO-induced JNK1/2 activation and apoptosis in rat MC.
Mammalian cells have developed a mechanism to diminish
unwanted, damaged, or futile cells. This process, known as
apoptosis, is initiated by diverse actions such as DNA dam-
age, growth factor withdrawal, or radical generation or as a
result of receptor occupancy. During the initiation of apopto-
sis, different proapoptotic and antiapoptotic proteins are
up- or down-regulated, thus promoting the activation of
caspases, chromatin condensation, and DNA fragmentation
(Hale et al., 1996). A tight regulation of apoptosis, similar to
proliferation, is indispensable to maintain a homeostatic cell
number otherwise resulting in pathological conditions, exem-
plified by inflammatory kidney diseases. Under conditions of
IgA nephropathy or anti-Thy1.1 nephritis, an early lysis of
glomerular mesangial cells (MC) is followed by mesangial
hypercellularity (Savill et al., 1995). Although hypercellular-
ity is a well recognized risk factor for progression to irrevers-
ible scarring, increases in the number of MC are reversible.
Removal of surplus MC mainly occurs by an apoptotic process
(Baker et al., 1994; Shimizu et al., 1995). This phenomenon
correlates with a significant production of nitric oxide (NO)
and can be prevented by pretreatment with the nitric oxide
synthase inhibitor NG-monomethyl-L-arginine (Cattel et al.,
1993). NO is synthesized by oxidation of L-arginine, catalyzed
by a family of NO synthases. Once NO is produced, it elicits
diverse physiological and pathophysiological functions such
as endothelium-dependent relaxation, neurotransmission,
cell-mediated immune responses, and induction of apoptosis
(Nathan, 1992; Brüne et al., 1998). Cellular toxicity of NO
may result from the interaction with oxygen, superoxide
(O2
2), or transition metals. In the case of O2
2, the NO/O2
2
reaction product can be cytotoxic or protective depending on
the cell type (Lin et al., 1995). In cultured rat MC, stimula-
tion with NO or O2
2 induces apoptosis, whereas the simul-
taneous generation of NO and O2
2 in a balanced proportion
is cell protective (Sandau et al., 1997a). However, underlying
mechanisms are still unclear.
Besides NO, growth factors (GFs) play an important role in
the pathogenesis of glomerular inflammation. Some of these
mediators stimulate proliferation, whereas others drive ex-
cessive matrix accumulation (Johnson et al., 1992). In addi-
tion, GFs promote MC survival by attenuating apoptosis
induced by serum withdrawal (Mooney et al., 1997). Studies
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in different cell types underscored the protective character of
GFs, also against NO toxicity (Spear et al., 1997), but exam-
inations in MC are elusive. Known targets for GFs or fetal
calf serum (FCS) are the p42/44 mitogen-activated protein
kinases (Ottlinger et al., 1993), which belong to the super-
family of serine/threonine kinases, named mitogen-activated
protein kinases (MAPK). MAPK, which also encompass the
stress-activated protein kinases c-Jun N-terminal kinases1/2
(JNK1/2), become activated by upstream kinase cascades via
dual tyrosine and threonine phosphorylation (Guan, 1994;
Seger and Krebs, 1995). Activated MAPK translocate in the
nucleus, where they phosphorylate transcription factors such
as ternary complex factor/Elk-1, c-Jun, or activating tran-
scription factor-2 (Robinson and Cobb, 1997). The individual
activation and cross-talk between MAPK family members
allow cells to react on a specific stimulus with proliferation,
differentiation, or death. The role of MAPK activation in
promoting cell death or survival is controversially discussed.
Some studies connect p42/44 MAPK activation with cell pro-
tection, whereas JNK1/2 activation is associated with apo-
ptosis (Jarvis et al., 1997; Wang et al., 1998). It is also
proposed that the balance between p42/44 MAPK and
JNK1/2 activation determines cytoprotection or destruction
(Xia et al., 1995; Sanchez-Perez et al., 1998).
The aim of our study was to analyze the modulatory role of
p42/44 MAPK and JNK1/2 in NO-evoked apoptosis and for
MC protection. We found a selective activation of JNK1/2 in
response to NO and Ro 318220, a JNK1/2 activator, and a
direct correlation of JNK1/2 activation and apoptosis. MC are
rescued from apoptosis by the addition of FCS or the forma-
tion of O2
2 relative to NO. Cell protection by FCS is achieved
by p42/44 MAPK activation, whereas cell survival as a result
of NO/O2
2 interaction is solely based on the compensatory
antioxidant effect of intracellular glutathione. We conclude
that individual MAPK family members and the glutathione-
redox system determine death and survival.
Experimental Procedures
Materials. Insulin, diphenylamine, triethanolamine, and L-buthi-
onine-sulfoximine were purchased from Sigma (Deisenhofen, Ger-
many). NADH and pyruvate were purchased from Boehringer Mann-
heim (Mannheim, Germany). RPMI 1640 and medium supplements
were ordered form Biochrom (Berlin, Germany). FCS was purchased
from Life Technologies (Berlin, Germany). Phosphospecific p42/44 an-
tibody was obtained from New England Biolabs GmbH (Schwalbach/
Taunus, Germany). The secondary antibody was purchased from
Promega/Serva (Heidelberg, Germany). JNK1/2 antibody was pur-
chased from Santa Cruz Biotechnology Inc. (Heidelberg, Germany).
Enhanced chemiluminescence detection reagents and [g-32P]ATP were
obtained from Amersham (Braunschweig, Germany). N-Acetyl-Asp-
Glu-Val-Asp-7 (DEVD)-amino-4-methylcoumarin (AMC), AMC, and
3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate were pur-
chased from Biomol (Hamburg, Germany). PD 98059, 2,3-dimethoxy-
1,4-naphtoquinone (DMNQ), and Ro 318220 came from Calbiochem
(Bad Soden, Germany). The glutathione-S-transferase (GST)-c-Jun (fu-
sion protein, 1/166) expression plasmid was kindly provided by Prof. P.
Angel (Heidelberg, Germany). S-nitrosoglutathione (GSNO) was syn-
thesized as described previously (Sandau et al., 1997a). All other chem-
icals were of the highest grade of purity and commercially available.
Culture of MC. Rat MC were cultured, cloned, and characterized
as described previously (Pfeilschifter and Vosbeck, 1991). Cells were
grown in RPMI 1640 supplemented with 10% FCS, 100 U/ml peni-
cillin, 100 mg/ml streptomycin, and 5 mg/ml bovine insulin. One day
before and during the experiments, cells were kept in medium with-
out FCS. Passages 10 to 25 of MC and 2.5 3 105 cells/assay were used
for DNA fragmentation, lactate dehydrogenase (LDH) release, or
caspase-3 activity analysis, whereas 5 3 106 cells/assay were used
for the kinase assay and the Western blot.
JNK1/2 Activity Assay. Confluent rat MC were incubated for the
times indicated, scraped off, centrifuged (5 min, 1200g), and resus-
pended in lysis buffer (20 mM Tris z HCl, pH 7.5, 1% Triton X-100,
10% glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM b-glycerophos-
phate, 2 mM sodium pyrophosphate, and 1 mM sodium vanadate).
Cells were kept on ice for 5 min, vortexed, and centrifuged (10,000g,
20 min, 2°C). Protein (300 mg) of the supernatant, in an equalized
sample volume, was used for immunoprecipitation. Anti-JNK1/2 an-
tibodies were added, followed by gentle rotation at 4°C for 2 h. After
protein A-Sepharose addition, immune complexes were further incu-
bated for 60 min. JNK1/2-protein A-Sepharose complexes were
washed two times with lysis buffer and once with kinase buffer (25
mM HEPES, pH 7.4, 25 mM b-glyerophosphate, 25 mM MgCl2, 1 mM
dithiothreitol (DTT), and 0.1 mM sodium vanadate). Immune com-
plexes were centrifuged (10,000g, 2 min, 4°C) and resuspended in 25
ml of kinase buffer with the addition of 2 mg of GST-c-Jun and 5 mCi
of [g-32P]ATP. Phosphorylation was performed for 20 min at 37°C.
Reactions were stopped by the addition of 25 ml of 23 SDS sample
buffer. Samples were boiled for 5 min at 95°C, and proteins were
separated on 10% SDS-polyacrylamide gels. Gels were fixed, dried,
and subjected to autoradiography.
Western Blot Analysis. After individual incubations, medium
was removed and cells were scraped into ice-cold PBS (supplemented
with 1 mM sodium vanadate, 1 mM sodium fluoride, and 1 mM
phenylmethylsulfonyl fluoride), centrifuged (700g, 10 min, 4°C), and
resuspended in 200 ml of lysis buffer (50 mM Tris, 5 mM EDTA, 150
mM NaCl, 0.5% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride,
1 mM sodium vanadate, and 1 mM sodium fluoride, pH 8.0). Cell
debris was sonicated with a Branson sonifier (10 s, duty cycle 100%,
output control 1) and centrifuged (14,000g, 15 min), and protein
content was measured. For equal protein loading, 150 mg of protein
was mixed with the same volume of 23 SDS sample buffer (125 mM
Tris z HCl, 2% SDS, 10% glycerin, 1 mM DTT, 0.002% bromophenol
blue, pH 6.9) and boiled for 5 min. Proteins were resolved on 10%
SDS-polyacrylamide gels and blotted onto nitrocellulose sheets. Mo-
lecular weight of corresponding proteins was determined in relation
to molecular weight rainbow marker. Transblots were washed with
TBS (140 mM NaCl, 50 mM Tris z HCl, pH 7.2) containing 0.06%
Tween-20 before blocking with TBS/5% skim milk. Phosphospecific
p42/44 MAPK antibodies, dissolved in TBS/5% skim milk at a final
concentration of 0.1 mg/ml, were incubated overnight at 4°C. Blots
were washed five times before the anti-rabbit peroxidase-labeled
secondary polyclonal antibody was added (1 h, diluted 1:10,000 in
TBS/0.5% milk). Blots were washed five times, followed by enhanced
chemiluminescence detection.
Fluorogenic Caspase-3 Assay. After individual incubations,
MC were recovered and centrifuged (1200g, 5 min). Pellets were
resuspended in lysis buffer [100 mM HEPES, pH 7.5, 10% sucrose,
0.1% 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate, 1
mM phenylmethylsulfonyl fluoride, and 10 mM DTT], left on ice for
30 min, sonified (Branson sonifier, 10 s, duty cycle 100%, output
control 1), and centrifuged (10,000g, 10 min, 4°C). Cytosolic protein
(30 mg) was incubated with 12 mM DEVD-AMC at 30°C. Substrate
cleavage was followed fluorometrically with excitation at 360 nm and
emission at 460 nm for 2 h. Substrate cleavage during the linear
phase of the reaction was quantified by internal AMC standards.
DNA Fragmentation. DNA fragmentation was quantified by use
of the diphenylamine assay as previously reported (Sandau et al.,
1997a). Briefly, after incubation, MC were resuspended in 250 ml of
10 mM Tris, 1 mM EDTA, pH 8.0 (TE buffer), and incubated with an
additional volume of lysis buffer (5 mM Tris, 20 mM EDTA, pH 8.0,
0.5% Triton X-100) for 30 min at 4°C. Centrifugation (10,000g, 15
min) allowed recovery of intact chromatin (pellet) and DNA frag-
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ments (supernatant). Pellets were resuspended in 500 ml of TE buffer
and again precipitated overnight with 500 ml of 10% trichloroacetic
acid at 4°C. After centrifugation (4000g, 10 min), the supernatant
was removed. After the addition of 150 ml of 5% trichloroacetic acid,
samples were boiled for 15 min. DNA contents were quantified using
the diphenylamine reagent. The percentage of cleaved DNA was
calculated as the ratio of the DNA content in the supernatant to the
amount in the pellet.
LDH Release. The percentage of LDH release from cells is a
determinant of cellular necrosis and expressed as the proportion of
LDH released into the medium compared with the total amount of
LDH present in intact cells. Total LDH was determined after cell
lysis with 0.1% Triton X-100. LDH activity was monitored by follow-
ing the oxidation of NADH as the decrease in absorbance at 334 nm.
Reactions were carried out in a triethanolamine buffer (50 mM
triethanolamine), pH 7.6, containing 5 mM EDTA, 127 mM pyru-
vate, and 14 mM NADH.
Statistical Analysis. Each experiment was performed at least
three times, and statistical analysis was performed using the two-
tailed Student‘s t test. Statistical probability is expressed as *p , .05
and **p , .01. Normal distribution of data is ensured. Otherwise,
representative data of at least three similar examinations are shown.
Results
JNK1/2 Activation by NO is Time- and Concentra-
tion-Dependent. Previous studies have shown that differ-
ent NO donors, such as GSNO, spermine-NO, and S-nitroso-
N-acetylpenicillamine, caused apoptosis in rat MC as
characterized by chromatin condensation, DNA fragmenta-
tion, and accumulation of the tumor suppressor p53 (Sandau
et al., 1997b). With the notion that activation of the JNK1/2
pathway may promote cell death (Jarvis et al., 1997;
Sanchez-Perez et al., 1998), we examined JNK1/2 activation
in response to the NO donor GSNO in rat MC.
GSNO (1 mM) time-dependently promoted JNK1/2 activa-
tion as determined in a direct kinase assay using the sub-
strate GST-c-Jun. Activation became evident after 1 h and
was strongest at 2 and 4 h. Although activity then declined,
it remained slightly elevated for the next 12 h (Fig. 1A). In
further experiments, we established a dose-dependent
JNK1/2 activity increase during a 4-h incubation period. Low
GSNO concentrations (250 mM, 4 h) activated JNK1/2, which
became more pronounced at higher concentrations and was
strongest at a 0.75 to 1 mM concentration of the NO donor
(Fig. 1B). JNK1/2 activation in response to NO is in close
correlation to GSNO-induced apoptosis as described in ear-
lier studies (Sandau et al., 1997b). Therefore, we assume a
participation of the JNK1/2 pathway in NO-mediated apo-
ptosis. In addition, we examined the time dependence of
GSNO-evoked p42/44 MAPK activation. Only high concen-
trations of the NO donor caused p42/44 MAPK activation
(Callsen et al., 1998), whereas 250 mM GSNO left p42/44
MAPK activation unaltered (data not shown). By proposing
activation of JNK1/2 in promoting apoptosis, it should be
possible to achieve cell death through manipulation of acti-
vation/deactivation of JNK1/2.
Ro 318220 Mediated JNK1/2 and Caspase-3 Activa-
tion. In the following experiments, we used the JNK1/2
activator Ro 318220 to determine whether sustained JNK1/2
activation evokes apoptosis in rat MC. Ro 318220, originally
characterized as a specific protein kinase C inhibitor (Davis
et al., 1992), was identified to activate JNK1/2 via inhibition
of mitogen-activated protein kinase phosphatase-1 (MKP-1)
expression (Beltman et al., 1996). As expected, we noticed a
significant increase in JNK1/2 activity after the addition of
Ro 318220 or after coincubation of Ro 318220 with GSNO.
For these experiments, rat MC were pretreated with 10
mM Ro 318220 for 30 min, followed by a 4-h lasting coincu-
bation period with vehicle or 250 mM GSNO. GSNO as well
as Ro 318220 activated JNK1/2, whereas coincubation of Ro
318220 with GSNO increased the effect (Fig. 2A). For control
reasons, we ensured that p42/44 MAPK remained unaffected
by Ro 3118220 treatment (data not shown).
Caspase-3 activation is considered a convenient marker of
apoptosis and is regarded as the point of no return in the
proapoptotic signaling cascade. GSNO induced the cleavage
of the fluorogenic caspase-3 substrate DEVD-AMC and pro-
moted AMC accumulation in apoptotic cells. AMC production
increased in response to 250 mM GSNO after an incubation
period of 8 h compared with unstimulated cells. A similar
increase in caspase-3 activity occurred after the treatment
with 10 mM Ro 318220 for 8 h. Coincubation of rat MC with
250 mM GSNO and 10 mM Ro 318220 significantly enhanced
GSNO-evoked caspase-3 activation (Fig. 2B). To ensure that
the effects of Ro 318220 are based on JNK1/2 activation and
not on side effects due to protein kinase C inhibition, we
repeated the experiments with staurosporine (40 nM), a well
known protein kinase C inhibitor. In contrast to Ro 318220,
staurosporine did not promote JNK1/2 activation, nor was
the apoptotic rate affected (data not shown). In conclusion,
JNK1/2 activation by Ro 318220 or GSNO is correlated to
apoptotic cell death in rat MC.
FCS Promoted Cell Survival via p42/44 MAPK Path-
way. MC elaborate diverse mechanisms to protect them-
selves against toxic insults. Protection is achieved via the
simultaneous generation of O2
2 relative to NO production
(Sandau et al., 1997a) and/or secretion of growth factors
(Mooney et al., 1997). Although these protective factors are
described, little is known about intracellular pathways that
signal cell survival.
To establish a protective role of FCS against NO-mediated
apoptosis, we assayed DNA fragmentation in response to 250
Fig. 1. Dose- and time-dependent JNK1/2 activation by GSNO. A, con-
fluent and quiescent rat MC were stimulated with 1 mM GSNO and
JNK1/2 activity was analyzed at times indicated. B, alternatively, MC
were exposed to increasing concentrations of GSNO for 4 h or remained as
controls. JNK1/2 activation was determined by a radioactive kinase assay
using GST-c-Jun as a substrate as described in the text. Blots are repre-
sentative of three similar experiments.
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mM GSNO with or without the further addition of 10% FCS.
Supplementation of FCS completely abrogated GSNO-in-
duced DNA fragmentation (Fig. 3). To unravel FCS-evoked
transducing pathways, we probed for p42/44 MAPK activa-
tion, which is considered a protective mechanism (Xia et al.,
1995; Wang et al., 1998). Incubations of MC with 10% FCS
resulted in rapid p42/44 MAPK activation (Fig. 3, inset)
when determined by Western blot analysis using a phos-
phospecific p42/44 MAPK antibody that showed reactivity to
the tyrosine-phosphorylated and thus activated forms of
p42/44 MAPK only. To elucidate any contribution of p42/44
MAPK activation during FCS-induced cell survival, we inter-
rupted p42/44 MAPK signaling by using 10 mM PD 98059,
an MAPK kinase-1 (MEK-1) inhibitor (Alessi et al., 1995).
MEK-1 is the immediate upstream kinase that phosphory-
lates and thereby activates p42/44 MAPK. The inhibitory
effect of PD 98059 toward FCS-induced p42/44 MAPK phos-
phorylation was ensured by a Western blot against the phos-
phorylated form of the p42/44 MAPK (Fig. 3, inset). During
DNA fragmentation analysis, PD 98059 (10 mM), incubated
for 24 h, slightly increased apoptotic cell death by itself.
Higher concentrations of PD 98059 were cytotoxic for MC
(data not shown); therefore, any inhibition of p42/44 MAPK
activity was compensated for by the onset of apoptosis, which
restricted the use of PD 98059 for detailed dose-response
studies. Importantly, PD 98059 partly reversed FCS-evoked
protection toward GSNO-mediated apoptosis (Fig. 3). This is
in correlation with the p42/44 MAPK activation pattern in
which 10% FCS initiated p42/44 MAPK phosphorylation,
even in the presence of 250 mM GSNO. GSNO itself had no
effect on p42/44 MAPK activation (data not shown); however,
p42/44 MAPK activation by FCS was suppressed by the ad-
dition of 10 mM PD 98059 (Fig. 3, inset). In conclusion, by
using PD 98059, our data implicate a protective principle of
FCS-activated p42/44 MAPK during NO-mediated apoptosis
in rat MC.
Coincubation of NO/O2
2 Abolished Caspase-3 and
JNK1/2 Activation. Besides FCS, the simultaneous gener-
ation of NO/O2
2 in a balanced ratio protects cultured rat MC
against the toxicity of NO or O2
2 when applied individually
(Sandau et al., 1997a). In corroboration with earlier reports,
we observed NO- or O2
2-induced apoptosis in rat MC. This
was verified in this study based on caspase-3 activation with
the notion that coincubation of NO and O2
2 was cross-pro-
tective (Fig. 4A).
The addition of 250 mM GSNO for 24 h increased caspase-3
activity compared with unstimulated controls. O2
2, gener-
ated by 1, 5, and 10 mM concentrations of the redox cycler
DMNQ, which penetrates the plasma membrane and re-
leases O2
2 inside the cell as measured by the cytochrome C
assay (data not shown), dose-dependently initiated caspase-3
activation (Fig. 4A).
In extending experiments, we coincubated MC with GSNO
(250 mM) and increasing DMNQ concentrations (1, 5, and 10
mM) for 24 h. Caspase-3 activity declined toward GSNO
treatment when cells were costimulated with GSNO and
DMNQ (Fig. 4A). Similar effects were seen by using other
NO- and O2
2-generating systems such as spermine-NO and
Fig. 2. Ro 318220 enhances GSNO-induced JNK1/2 and caspase activa-
tion. MC were exposed to GSNO (250 mM), the MKP-1 inhibitor Ro
318220 (10 mM), or remained as controls. Ro 318220 was preincubated for
30 min. A, JNK1/2 activity was analyzed in a radioactive kinase assay
after a 4-h incubation period. B, caspase-3 activity was determined by the
cleavage of DEVD-AMC after 8 h. For details, see Experimental Proce-
dures. GSNO-induced caspase-3 activation was set 100%, and other val-
ues were calculated proportionally to GSNO. Caspase-3 activity values
are the mean 6 S.D. of four different experiments (**significant versus
GSNO-treated cells), whereas the kinase assay is representative of four
similar experiments.
Fig. 3. GSNO-induced apoptosis is attenuated by FCS via p42/44 MAPK
activation. Inset, MC were exposed to vehicle (lane 1), 10% FCS (lanes 2
and 3), 10% FCS in combination with 10 mM PD 98059 (lane 4), 250 mM
GSNO (lane 5), or both agents (lane 6). Activation/phosphorylation of
p42/44 MAPK was detected as outlined in Experimental Procedures by
Western blot analysis with a phosphospecific p44/42 MAPK antibody
(p42P/p44P). p42/44 MAPK activation in lanes 1 and 2 was detected after
5 min, whereas the inhibitory effect of PD 98059 was analyzed after 24 h
(lanes 3–6). For DNA fragmentation, MC were cultured for 24 h with or
without 10% FCS, the MEK-1 inhibitor PD 98059 (10 mM), and/or GSNO
(250 mM) as indicated. DNA fragmentation was quantified using the
diphenylamine assay described in the text. Data are mean 6 S.D. values
of at least five separate experiments (pp, a, significant versus control, pp,
b , significant versus GSNO, p, c , significant versus GSNO/FCS).
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the hypoxanthine/xanthine oxidase system. After the as-
sumption that JNK1/2 activation is associated with apopto-
sis, we determined phosphorylation of GST-c-Jun under con-
ditions of NO/O2
2 cogeneration. Interestingly, GSNO (250
mM, 4 h)-induced JNK1/2 activation was reduced with in-
creasing DMNQ concentrations. Activation vanished com-
pletely with the combination of GSNO (250 mM) and 10 mM
DMNQ (Fig. 4B). Intriguingly, GSNO/DMNQ coincubation
did not activate p42/44 MAPK (data not shown). In line, PD
98059 left NO/O2
2-mediated protection unaltered as deter-
mined by DNA fragmentation and caspase-3 activation anal-
ysis (data not shown). These examinations propose that pro-
tection evoked by NO/O2
2 coformation is p42/44 MAPK
independent.
NO/O2
2 Protection Demands Intracellular GSH. The
intracellular redox agent GSH plays a crucial role in inter-
cepting oxidative and/or nitrosative stress and therefore is an
important determinant in controlling stress-evoked apopto-
sis. To assess the role of intracellular GSH in NO/O2
2-medi-
ated protection in rat MC, we depleted the GSH pool by 90%
with a 24-h lasting addition of 500 mM L-buthionine-sulfox-
amine (BSO; data not shown), a specific g-glutamylcysteine
synthetase inhibitor that blocks the rate-limiting step of
GSH synthesis (Richman et al., 1973).
In a first set of experiments, we analyzed DNA fragmen-
tation and LDH release as a result of 250 mM GSNO or 10 mM
DMNQ addition (Table 1). The simultaneous addition of
GSNO and DMNQ significantly lowered DNA fragmentation
and LDH release compared with GSNO as shown in Table 1.
Reduced DNA fragmentation achieved by NO/O2
2 coincuba-
tion did not result in a shift toward necrosis as confirmed by
LDH measurements. However, GSH depletion by BSO en-
hanced GSNO-evoked cytotoxicity, shifting apoptosis to ne-
crosis. Lowering GSH also completely abolished NO/O2
2-
mediated protection, resulting in enhanced apoptosis and
necrosis (Table 1) and thus suggesting GSH is a critical
parameter for NO/O2
2-mediated cell protection in rat MC.
We further verified these results for JNK1/2 activation
(Fig. 5). Kinase assays revealed that BSO (500 mM, 24 h)
treatment did not activate JNK1/2. However, GSNO (250
mM, 4 h)-evoked JNK1/2 activation was dramatically en-
hanced by BSO prestimulation (Fig. 5A). In addition, GSH-
depleted cells showed massive JNK1/2 activation after a 4-h
lasting exposure period with GSNO (250 mM) and DMNQ (10
mM) that otherwise was abrogated in GSH-containing cells
(Fig. 5B). GSH depletion obviously eliminates NO/O2
2-medi-
ated protection and reestablishes JNK1/2 activation.
Ro 318220 Abolished NO/O2
2-Mediated Protection.
To position JNK1/2 as a downstream event during NO/O2
2
protection, we investigated apoptotic cell death under condi-
tions of NO/O2
2 cogeneration in response to Ro 318220. MC
were treated with 10 mM Ro 318220 in the presence or
absence of 250 mM GSNO and 10 mM DMNQ for 4 h. Activa-
tion of JNK1/2 was evident in response to Ro 318220 but was
absent in GSNO/DMNQ-treated cells. Coincubation of Ro
318220, GSNO, and DMNQ resulted in JNK1/2 activation
(Fig. 6A). These data were further confirmed during DNA
fragmentation analysis.
Exposure of MC for 24 h with 250 mM GSNO resulted in
24% DNA fragmentation, whereas coincubation with 10 mM
DMNQ significantly reduced DNA fragmentation. In line
with caspase-3 activation (Fig. 2B), Ro 318220 also promoted
massive DNA fragmentation. Coincubation of Ro 318220
with GSNO/DMNQ for 24 h completely abrogated the GSNO/
DMNQ-induced protective principle and allowed 40% DNA
fragmentation (Fig. 6B). With respect to initiation of apopto-
sis, we suggest that JNK1/2 activation can be positioned
Fig. 4. GSNO-induced caspase-3 and JNK1/2 activation is abrogated by
DMNQ. Rat MC were cultured in the absence or presence of 250 mM
GSNO and/or increasing concentrations of DMNQ (1, 5, and 10 mM). A,
caspase-3 activation was determined by the cleavage of DEVD-AMC after
24 h as described in Experimental Procedures. GSNO-induced caspase-3
activation was set at 100%, and other values were calculated proportion-
ally to GSNO. Data are mean 6 S.D. values of five separate experiments
(pp, a, significant versus control; pp, b, significant versus GSNO). B,
JNK1/2 activation was measured after 4 h by a direct kinase assay using
GST-c-Jun as a substrate. The blot is representative for three similar
experiments.
TABLE 1
GSNO/DMNQ-evoked protection was attenuated by glutathione
depletion
MC were preincubated for 24 h with or without BSO (500 mM). Then, vehicle
(control), GSNO (0.25 mM), DMNQ (10 mM), or the combination of GSNO and DMNQ
was added for 24 h. DNA fragmentation was quantified by the diphenylamine assay,
and necrosis was measured by LDH release. For details, see Experimental Proce-
dures. Data are mean values (6S.D.) of more than four separate experiments.
DNA Fragmentation LDH Release




Control 9 6 2 14 6 3 6 6 2 8 6 2
GSNO (0.25 mM) 24 6 5 26 6 3 16 6 3 40 6 4c
DMNQ (10 mM) 13 6 2 20 6 2 5 6 1 13 6 4
GSNO (0.25 mM) 1
DMNQ (10 mM)
17 6 2a 25 6 2 7 6 0d 45 6 3b
a Significant versus GSNO without BSO (DNA fragmentation).
b Significant versus GSNO/DMNQ without BSO (LDH release).
c Significant versus GSNO without BSO (LDH release).
d Significant versus GSNO without BSO (LDH release).
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downstream of the point at which NO/O2
2-mediated protec-
tion interferes because JNK1/2 activation as a result of
MKP-1 inhibition circumvents NO/O2
2-evoked cell survival.
Discussion
Apoptosis is an indispensable and continuously occurring
process that eliminates obsolete, damaged, or futile cells,
whereas uncontrolled apoptosis culminates in various dis-
eases. The induction of apoptosis in response to various ago-
nists is dependent on the signal strength, cellular self-de-
fense mechanisms, and promoting or antagonizing signaling
pathways. NO represents a stimulus with diverse properties.
When produced at low concentrations, NO elicits cGMP-de-
pendent, physiological functions (Schmidt and Walter, 1994).
In contrast, under inflammatory settings, large amounts of
NO are generated, which lead to cell destruction as described
for mesangiolysis during proliferative glomerulonephritis
(Cattell et al., 1993). NO-induced apoptosis has been shown
for macrophages, neurons, and thymocytes among others
(Brüne et al., 1998). In MC, NO initiates typical apoptotic
features such as DNA fragmentation, chromatin condensa-
tion, and terminal deoxynucleotidyl transferase biotin-dUTP
nick end labeling-positive reactions, which are preceded by
accumulation of the tumor suppressor p53 and Bax (Sandau
et al., 1997b) and down-regulation of the antiapoptotic pro-
tein Bcl-2 (K.B.S. and B.B., unpublished data). Altered pro-
tein expression occurs between 2 and 4 h after NO stimula-
tion, but earlier signaling pathways remain unknown.
Therefore, we concentrated on the JNK1/2 pathway, which is
proposed as an early signal transduction mechanism associ-
ated with cell death. In line with an earlier observation
(Pfeilschifter and Huwiler, 1996), we noticed a concentration-
and time-dependent JNK1/2 activation by NO (Fig. 1, A and
B). To establish a correlation between JNK1/2 activation and
mesangial cell death, we manipulated JNK1/2 activation/
deactivation by using the MKP-1 phosphatase inhibitor Ro
318220. MKP-1 was shown to dephosphorylate/inactivate
JNK1/2, and therefore, treatment with Ro 318220 evoked
JNK1/2 activation (Beltman et al., 1996). JNK1/2 activation
as a result of Ro 318220 treatment was established (Fig. 2A,
lane 2) in a JNK1/2 kinase assay with GST-c-Jun as the
substrate, with the notion that coincubation of Ro 318220
and GSNO even enhanced JNK1/2 activity. By measuring
caspase-3 activation (Fig. 2B), we demonstrated a direct cor-
relation of JNK1/2 activation and the rate of apoptosis. Con-
clusively, the JNK1/2 pathway is an important and early
signal transducing mechanism in NO-induced apoptosis in
rat MC. For RAW macrophages, we have shown earlier in
antisense experiments that JNK1/2 is located upstream of
p53 accumulation in the NO-initiated apoptotic pathway
(Callsen and Brüne, 1999), whereas others have described
that JNK1/2 can phosphorylate p53 and thus prolong its
half-life (Fuchs et al., 1997, 1998). These interactions may
explain how JNK1/2 activation promotes apoptosis.
As discussed earlier, the apoptosis-inducing abilities are
affected by other mediators such as oxidants or cytokines; in
Fig. 5. Depletion of GSH enhanced JNK1/2 activation. Rat MC were
exposed to 250 mM GSNO (A) or the combination of GSNO/10 mM DMNQ
(B) or were kept as controls for 4 h. BSO (500 mM) was preincubated for
24 h. JNK1/2 activity was measured in a direct kinase assay as described
in the text. Results are representative of five separate experiments.
Fig. 6. Ro 318220 abolished GSNO/DMNQ-elicited protection. Rat MC
were stimulated with GSNO (250 mM) and/or DMNQ (10 mM) with or
without 10 mM Ro 318220. A, JNK1/2 activity was measured after 4 h in
a direct kinase assay. B, DNA fragmentation was determined after 24 h
using the diphenylamine assay as outlined in Experimental Procedures.
Results are mean 6 S.D. values of five separate experiments (pp, a,
significant versus control; pp, b, significant versus GSNO; pp, c, significant
versus GSNO/DMNQ). The blot is representative for three similar exper-
iments.
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addition, they are controlled by cellular self-defense mecha-
nisms. This is exemplified for the NO system. Although NO
generally induces apoptosis in MC, endogenously produced
NO is not toxic. Detoxification of endogenously produced NO is
achieved via the simultaneous generation of O2
2 (Sandau et al.,
1997a). Experimentally, this is reproduced by the addition of a
NO donor in combination with an O2
2generating system. Here,
we used GSNO and the redox cycler DMNQ, but combinations
of spermine-NO with DMNQ or the O2
2-generating hypoxan-
thine/xanthine oxidase system work equally well (Sandau et al.,
1997a). Based on caspase-3 activity determinations as an apo-
ptotic marker, we proved GSNO and DMNQ coincubation in a
balanced ratio was cell protective compared with the agonist
GSNO (Fig. 4A). The coincidence of NO and O2
2 is not re-
stricted to cells that specifically generate NO and O2
2 but may
also occur under inflammatory conditions as a result of infiltra-
tion of activated immune cells. Once NO and O2
2 are produced,
they react with each other in a diffusion-controlled reaction,
resulting in the formation of peroxynitrite (Stamler, 1994). Per-
oxynitrite is a potential cytotoxic agent due to its oxidizing
abilities. In cerebrocortical cultures or PC12 cells, peroxynitrite
leaves the hallmarks of toxicity (Bonfoco et al., 1995; Spear et
al., 1997), but the interaction is also established as a cellular
protective mechanism during ischemia-reperfusion or myocar-
dial injury (Lefer et al., 1997; Nossuli et al., 1997). However,
detailed mechanisms remain elusive. In MC, NO/O2
2 coincu-
bation abrogated JNK1/2 activation (Fig. 4B) and reduced
caspase-3 activation (Fig. 4A). Previously, we noticed that NO/
O2
2 cogeneration attenuated p53 and Bax accumulation
(Sandau et al., 1997b), elicited Bcl-2 up-regulation (K.B.S. and
B.B., unpublished data), and blocked DNA fragmentation
(Sandau et al., 1997a). Because some studies connect p42/44
MAPK phosphorylation with cell protection (Xia et al., 1995;
Wang et al., 1998), we analyzed whether an attenuated JNK1/2
activity was shifted toward p42/44 MAPK activation. This was
ruled out by not observing p42/44 MAPK phosphorylation and
by the lack of the MEK inhibitor PD 98059 interference (data
not shown). We conclude that NO/O2
2-evoked cytoprotection is
p42/44 MAPK independent. Wink et al. (1997) showed that
generation of O2
2 quenched NO-mediated nitrosative reactions,
thus resembling a shift from nitrosative to oxidative stress.
Consequently, nitrosative stress decreased, whereas oxidative
stress increased. The GSH system is established to be a first-
line defense mechanism against oxidants. Under our conditions
of NO/O2
2 coexistence, we measured a significant and long-
lasting accumulation of oxidized GSH compared with the oxi-
dative capacity initiated by NO or O2
2 itself (K.B.S. and B.B.,
unpublished data). This is in line with in vitro experiments in
which oxidized GSH is formed in the presence of a NO donor,
the xanthine oxidase system, and GSH (Wink et al., 1997). This
encouraged us to analyze the role of GSH by using BSO to
deplete intracellular GSH. GSH depletion sensitized MC to-
ward apoptosis and necrosis (Table 1) and abrogated the pro-
tective effect of NO/O2
2 cogeneration. Notably, increased apo-
ptosis again was accompanied by JNK1/2 activation (Fig. 5). It
seems that GSH-mediated quenching of the oxidative stress
that occurs as a result of the NO/O2
2 interaction is primarily
responsible for protection. Attenuation of apoptosis by NO/O2
2
formation interferes upstream of JNK1/2 as stimulation with
Ro 318220 reestablished JNK1/2 activation and apoptosis (Fig.
6, A and B).
In addition to the NO/O2
2 radical-radical interaction, al-
ternative protective mechanisms against NO-induced toxic-
ity may operate. In RAW 264.7 macrophages, cyclooxygen-
ase-2 expression protects against NO-evoked apoptosis (von
Knethen and Brüne, 1997); in hepatocytes, HSP 70 expres-
sion confers resistance (Kim et al., 1997); and activation of
phosphatidylinositol 3-kinase mediates protection against
peroxynitrite in PC12 cells (Spear et al., 1997). Often, cyto-
kines or growth factors circumvent cell death under various
settings. For MC, Mooney et al. (1997) reported that insulin-
like growth factor (IGF)-I and -II and basic fibroblast growth
factor suppressed apoptosis induced by serum deprivation,
whereas transforming growth factor-b1, epidermal growth
factor, and platelet-derived growth factor had no effect. IGF-I
and -II also provided protection from etoposide- or cyclohex-
imide-induced apoptosis (Mooney et al., 1997), although re-
sponsible mechanisms remained largely unknown. There-
fore, we intended to corroborate protection by using FCS and
specifically to address the likely involvement of MAPK. Our
results (Fig. 3) show that 10% FCS protected MC against
NO-induced DNA fragmentation by p42/44 MAPK phosphor-
ylation. A cause-effect relation between MAPK activation
and protection was established by the addition of the MEK
inhibitor PD 98059. PD 98059 significantly abrogated FCS-
evoked protection. These results support the concept that
p42/44 MAPK activation conveys protection in MC. A similar
mechanism has been described for primary rat cerebellar
granule neurons in which the pituitary adenylate cyclase-
activating polypeptide 38 induced protection against potas-
sium deprivation via p42/44 MAPK activation through a
cAMP-dependent pathway (Villalba et al., 1997).
In conclusion, the inflammatory mediator NO can induce
apoptosis in rat MC through JNK1/2 activation. At the same
time, cells elaborated different mechanisms to protect them-
selves. The simultaneous generation of NO and O2
2 allows
avoidance of radical-induced toxicity as long as reduced GSH
is present, whereas FCS conveys protection by causing
p42/44 MAPK activation.
The involvement of different signaling pathways empha-
sizes how agonists such as IgA or anti-Thy1.1 antibodies can
trigger a complex phenomenon such as glomerulonephritis
that encompasses mesangial cell proliferation and cell death.
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